Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $2.98 USD
Change Today +0.08 / 2.76%
Volume 381.1K
RIGL On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 09/4/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Thomas A. Raffin M.D.

AgeTotal Calculated CompensationThis person is connected to 39 board members in 3 different organizations across 6 different industries.

See Board Relationships
68--

Background*

Dr. Thomas A. Raffin, also known as Tom, MD is a Co-Founder at Rigel Pharmaceuticals, Inc. He co-founded Rigel Pharmaceuticals, Inc. in 1996. Dr. Raffin is also a Senior Partner at Telegraph Hill Partners. He joined Telegraph Hill Partners as a Partner in 2001. Dr. Raffin is an Advisor to numerous other companies. He founded the firm. Over the past two decades he has worked extensively in the healthcare and medical device sectors. Dr. Raffin was an Advisor to Cell Therapeutics ...

Read Full Background

Corporate Headquarters*

1180 Veterans Boulevard
South San Francisco, California 94080

United States

Phone: 650-624-1100
Fax: 650-624-1101

Board Members Memberships*

Director
1999-Present
Lead Independent Director, Chairman of Compensation Committee and Chairman of Nominating & Corporate Governance Committee
2006-Present
Director

Education*

BA
Stanford University
MD
Harvard University
MD
Stanford University School of Medicine

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RIGL:US $2.98 USD +0.08

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jack Lief Ph.D.Co-Founder, Chairman, Chief Executive Officer, President and Principal Financial Officer
Arena Pharmaceuticals, Inc.
$746.8K
Paolo Pucci Chief Executive Officer and Director
ArQule Inc.
$489.3K
James A. Bianco M.D.Principal Founder, Chief Executive Officer, President, Executive Director, Member of Scientific Advisory Board and Member of Executive Committee
CTI BioPharma Corp.
$1.3M
Mark R. Baker J.D.Chief Executive Officer, Director and Member of Science & Strategy Committee
Progenics Pharmaceuticals, Inc.
$555.7K
Myung-Joong Cho Ph.D.Founder, Chief Executive Officer and President
CrystalGenomics, Inc.
--
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact RIGEL PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.